Unlike in solid tumors, where activation of p38 MAPK-MK2 induces resistance by arresting the cell cycle [30, 67, 68], p38 MAPK inhibition did not affect the cell cycle in AML cells (Additional file 1: Figure S4D). Here, MAPKAPK2 is linked to acute myeloid leukemia.